April 15, 2015

The Cardinal Health Foundation and the American Pharmacists Association recently recognized pharmacists for their efforts in prescription medication misuse prevention.

April 14, 2015

DSN editor in chief Rob Eder talks about why Congress needs to rethink current DEA regulations that block access to medications to chronic pain patients.

 

April 14, 2015

ANI Pharmaceuticals banking on strong growth in generics. 

April 14, 2015

Total dollars spent on prescriptions in the U.S. were up 13.1%.

April 14, 2015

Actavis and Medicines360, a nonprofit women’s health pharmaceutical company, on Monday announced that Liletta (levonorgestrel-releasing intrauterine system) in 52 mg is now available in the United States.

April 14, 2015

IBM creates new business unit to manage a HIPAA-enabled cloud offering that will help augment big data analysis of chronic disease states. 

April 14, 2015

Taiwan-based drug development company Sunny Pharmtech and Vitruvias Therapeutics, a generic drug development company, on Tuesday announced that they will team up to co-develop a portfolio of generic drug products.

April 13, 2015

WebMD is set to release a robust medication reminder function specifically designed for its Apple Watch app. 

April 8, 2015

Mylan on Wednesday announced a proposal to acquire Perrigo in $29 billion deal. 

April 7, 2015

A new policy statement issued by American Academy of Pediatrics urges use of metric system in dosing children. 

 

April 7, 2015

Mylan on Tuesday announced the launch of norethindrone and ethinyl estradiol tablets (chewable) 0.8 mg/0.025 mg and ferrous fumarate tablets, 75 mg (chewable).

April 7, 2015

Private health insurance exchange enrollment doubled to 6 million covered, accordiing to an Accenture report released Tuesday. 

April 7, 2015

The Canadian Generic Pharmaceutical Association on Tuesday established a new Biosimilars Board. 

 

 

April 7, 2015

The disparity between reimbursement rates and generic drug costs caused by a lag in payment is forcing many community pharmacies to operate at a negative margin.

April 6, 2015

Public health exchange enrollees fill more prescriptions, but also opt more often for generics or 90-day fills, than their commercial plan counterparts. 

 

April 2, 2015

Sam's Club on Thursday sweetened the pot for its Plus and Business Plus members with an offering of five generic prescriptions without charge in most states. 

April 2, 2015

Alere's i Strep A test received marketing clearance from the Food and Drug Administration on Thursday. 

April 1, 2015

Dr. Reddy's Laboratories on Wednesday acquired UCB's portfolio of dermatology, respiratory and pediatric products. 

April 1, 2015

The cost of treating rheumatoid arthritis will reach $9.3 billion by 2020, according to a GBI Research report released Wednesday. 

March 31, 2015

Amneal Pharmaceuticals will acquire Actavis Australia's generic pharmaceutical business. Financial terms of the agreement were not disclosed. 

March 31, 2015

The director of the FDA’s Office of Generic Drugs temporarily steps down to deal with a medical issue, according to a report by the Regulatory Focus Professionals Society.

March 31, 2015

Teva Pharmaceutical Industries announced the launch of generic Exforge (amlodipine and valsartan) tablets, which are indicated for the treatment of hypertension. 

 

March 30, 2015

Teva Pharmaceutical Industries and Auspex Pharmaceuticals announced an agreement under which Teva will acquire Auspex in a deal valued at $3.2 billion.

March 27, 2015

More than 350 pharmacy advocates headed to Capitol Hill for the seventh annual NACDS RxIMPACT Day to further reinforce the recognition by lawmakers of the evolving role of pharmacy in patient care and educate members of Congress about pro-patient, pro-pharmacy policy.